Cambridge Cognition Holdings Plc

Cambridge Cognition Holdings Plc

COG · LSE · Healthcare / Health Information Services

29.00GBX+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close29.00
Open29.00
Day Range28.10 – 31.00
52-Week Range26.60 – 45.00
Volume124.60K
Market Cap15.11M
P/E (TTM)0.00
Forward P/E67.11
EPS-0.03
Dividend Yield0.00%
Beta0.80
50-Day Avg30.58
200-Day Avg34.25

About

Cambridge Cognition Holdings Plc develops and markets digital solutions for the assessment of brain health in the United States, United Kingdom, the European Union, and internationally. The company offers sensitive, precise and objective measures of cognitive function, correlated to neural networks; voice analysis, an automated speech recognition tool for monitoring neurological and psychiatric disorders; and high frequency testing that detects fluctuations in brain health with short tasks over regular timepoints. It also provides electronic questionnaires and scales (eCOA), a digital bespoke questionnaires that collects data within tight deadlines; and data quality management. Cambridge Cognition Holdings Plc was incorporated in 2012 and is headquartered in Cambridge, the United Kingdom.

Company Details

  • SectorHealthcare
  • IndustryHealth Information Services
  • CEOMr. Robert Baker
  • Employees74
  • HeadquartersTunbridge Court, Cambridge, United Kingdom, CB25 9TU, UK
  • Websitehttps://www.cambridgecognition.com

Leadership

  • Mr. Robert BakerCEO, Joint MD & Senior Executive Director · b. 1987
  • Mr. James Ronald OpenshawCFO, Head of Corporate Development & Director · b. 1967
  • Mr. John HammondCo-Founder
  • Ms. Francesca Cormack Ph.D.Chief Scientist & Member of Scientific Advisory Board
  • Mr. Simon MerrittMarketing and Communications Director
  • Mr. Nick TaptiklisHead of R&D
  • Simon McKeatingCompany Secretary
  • Prof. Trevor Robbins CBE, FBPsS, FMedSci, FRS, Ph.D.Senior Consultant
  • Prof. Barbara Sahakian FBPsS, FMedSciSenior Consultant

Financials

Income Statement

Currency: GBP2010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue4.83M5.58M5.68M4.15M5.80M5.04M6.88M6.73M6.13M5.04M6.74M10.09M12.61M13.52M10.34M9.40M
Growth (%)-+15.56%+1.86%-27.02%+39.87%-13.10%+36.37%-2.12%-8.86%-17.80%+33.70%+49.74%+24.96%+7.15%-23.48%-9.11%
Cost of Revenue805.38K919.46K1.22M490.00K866.00K590.00K986.00K622.00K900.00K1.15M1.32M2.02M3.29M2.72M1.96M2.39M
Gross Profit4.02M4.66M4.47M3.66M4.94M4.45M5.89M6.11M5.23M3.89M5.42M8.08M9.32M10.80M8.39M7.01M
Gross Margin83.32%83.52%78.58%88.19%85.07%88.30%85.66%90.76%85.33%77.21%80.36%80.04%73.91%79.90%81.10%74.53%
Operating Expense3.10M4.64M5.92M6.62M5.24M5.11M5.77M6.39M6.72M6.94M5.96M7.82M10.26M14.10M9.55M8.56M
Operating Income921.41K15.23K-1.45M-2.96M-304.00K-659.00K116.00K-284.00K-1.49M-3.05M-546.00K264.00K-936.00K-3.31M-1.17M-1.55M
Operating Margin19.08%0.27%-25.58%-71.31%-5.24%-13.07%1.69%-4.22%-24.26%-60.45%-8.10%2.62%-7.42%-24.45%-11.28%-16.50%
EBITDA944.05K43.06K-1.42M-2.92M-266.00K-811.00K184.00K-207.00K-1.43M-2.95M-502.00K412.00K-514.00K-2.62M-542.00K-960.00K
EBITDA Margin19.55%0.77%-24.92%-70.27%-4.58%-16.08%2.68%-3.08%-23.33%-58.53%-7.45%4.08%-4.08%-19.42%-5.24%-10.21%
Net Income719.61K-160.72K-1.58M-2.86M-173.00K-782.00K272.00K-257.00K-1.44M-2.90M-438.00K450.00K-409.00K-3.51M-1.78M-1.68M
Net Income Margin14.90%-2.88%-27.73%-68.97%-2.98%-15.51%3.96%-3.82%-23.51%-57.54%-6.50%4.46%-3.24%-25.96%-17.26%-17.82%
R&D---1.24M1.24M1.30M890.00K1.13M1.41M1.72M1.45M1.66M2.17M3.85M2.56M2.43M
R&D as % of Total Revenue---29.89%21.41%25.86%12.94%16.78%23.05%34.01%21.55%16.45%17.16%28.46%24.74%25.85%
Interest Expense201.80K175.96K122.19K35.00K000004.00K9.00K11.00K16.00K168.00K563.00K332.00K
Interest Expense % of Total Revenue4.18%3.15%2.15%0.84%0.00%0.00%0.00%0.00%0.00%0.08%0.13%0.11%0.13%1.24%5.44%3.53%

Balance Sheet

Currency: GBP2010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets3.40M3.66M2.40M3.77M3.75M2.95M5.07M4.58M3.45M3.16M6.26M12.54M15.11M14.23M13.03M11.28M
Total Liabilities3.64M4.03M4.08M1.64M1.70M1.53M2.21M1.55M3.98M4.10M6.21M11.91M15.01M12.95M9.67M8.29M
Total Equity-240.29K-375.68K-1.68M2.13M2.05M1.41M2.91M3.03M-526.00K-944.00K57.00K632.00K95.00K1.28M3.36M2.99M
Cash1.17M1.39M641.04K2.26M1.52M756.00K2.38M1.86M1.11M901.00K3.05M6.81M8.32M3.22M1.29M1.13M
Total Debt---------92.00K98.00K18.00K18.00K2.56M1.91M873.00K
Net Debt-1.17M-1.39M-641.04K-2.26M-1.52M-756.00K-2.38M-1.86M-1.11M-809.00K-2.95M-6.79M-8.30M-660.00K613.00K-254.00K

Cash Flow

Currency: GBP2010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow550.16K535.21K-700.75K-2.47M-693.00K-708.00K473.00K-624.00K-644.00K-2.31M1.01M3.93M1.68M-4.97M-3.08M-232.00K
Investing Cash Flow-32.12K-40.40K-54.92K-321.00K-49.00K-133.00K-44.00K-48.00K-25.00K-55.00K-42.00K-105.00K-189.00K-3.02M50.00K-30.00K
Financing Cash Flow-199.76K-276.68K5.49K4.41M78.00K78.00K1.14M193.00K-51.00K2.16M1.16M-86.00K-132.00K2.88M1.13M152.00K
Capital Expenditure32.12K40.40K54.92K21.00K49.00K133.00K44.00K48.00K25.00K55.00K42.00K56.00K189.00K33.00K3.00K30.00K
Free Cash Flow518.04K494.81K-755.66K-2.49M-742.00K-841.00K429.00K-672.00K-669.00K-2.37M972.00K3.88M1.49M-5.00M-3.09M-262.00K
FCF to OCF94.16%92.45%107.84%100.85%107.07%118.79%90.70%107.69%103.88%102.38%95.86%98.58%88.73%100.66%100.10%112.93%

Earnings

Report DateSep 20, 2018
EPS Estimate-
EPS Actual0.09
Surprise-
Timing-

Key Statistics & Ratios

Market Cap15.11M
Enterprise Value14.77M
Trailing P/E0.00
Forward P/E67.11
PEG Ratio0.00
Price / Sales1.49
Price / Book6.90
EPS-0.03
Book Value0.064
Revenue (TTM)10.13M
Gross Profit (TTM)7.66M
EBITDA-489.00K
Profit Margin-13.86%
Operating Margin-12.41%
Return on Equity-62.08%
Return on Assets-5.75%
Shares Outstanding53.98M
Shares Float24.94M
Beta0.80
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%